药物对比
Dapagliflozin vs Linagliptin
比较Dapagliflozin与Linagliptin治疗2型糖尿病。SGLT2抑制剂与DPP-4抑制剂：疗效、心脏/肾脏获益、副作用，以及哪种可能更适合您。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting an add-on oral agent for type 2 diabetes in patients with or at high risk for cardiovascular disease, heart failure or chronic kidney disease.
结论
Dapagliflozin generally offers extra cardiorenal benefits over linagliptin, but neither is universally superior and selection must be personalized by a clinician.
全部药物对比